While PRKAR1A, PIK3CA (Q546E) and KRAS mutation (G12V), mutations have been detected in a minority of OMs [29, 30] and GNAS1 mutations are well described in intramuscular myxomas, neither has emerged as a consistent molecular feature of OMs. Here, PRKAR1A is linked to opsoclonus-myoclonus syndrome.